Issues

Health Care

Publications

By / 10.29.2014

The shift to data-driven growth is one of the most important forces behind the strong performance of the U.S. economy in recent years. Online sales are up by 16% over the past year, and Americans are getting more and more of their information online. Indeed, data-related products and services account for roughly 30% of real […]

By / 2.5.2013

This brief provides a new explanation for why healthcare cost growth is showing restraint. Specifically, we find evidence that the healthcare sector is finally managing to use its workers more productively. In this policy brief we define a new measure of healthcare productivity, Gross Medical Productivity (GMP). We define GMP as the number of potential […]

By and / 3.5.2012

Most Americans are painfully aware that their health care premiums are rising faster than other necessities of life. Many also know that their earnings are growing slowly or not at all, despite apparent increases in worker productivity. These problems have been widely reported, but are seldom linked. Yet they are directly connected. The costs of […]

Press

By / 12.11.2015

An unfortunate refrain among Democratic presidential hopefuls is that rapacious pharmaceutical and biotech companies are driving up the cost of essential medications, bankrupting the health-care system, and depriving sick Americans of treatment. Hillary Clinton has honed her message to a nice sound bite: Drug companies that charge excessively high prices “are making a fortune off […]

By / 6.19.2015

As the presidential campaign season gets underway, it reminds us how much we loath the politics of fear mongering. Half-truths and half-baked policy proposals have become staples of modern campaigns. You betcha! Until recently, there was a difference between campaigning and governing. Governments are supposed to base their decisions on hard facts and real science. […]

By / 5.11.2015

The Food and Drug Administration (FDA) is fast finding itself at the center of the debate over healthcare regulation in the 21st century. At issue: to embrace the power of data-driven innovation, or to stand by the current regulatory paradigm. Fortunately, two major Congressional initiatives may be the push the FDA needs to see the […]

Blog

By / 5.6.2016

Productivity growth in the United States continues to slump.  The latest numbers from the BLS show that multifactor productivity growth was only a tiny 0.2% in 2015. In particular, gross medical productivity of the US healthcare system fell by 1.2% in 2015, according to PPI’s calculations.* That’s after two years of ticking up slightly. Falling […]

By / 5.7.2015

Our recent report on tech employment, authored by myself and Diana Carew,  calculated that women have been getting three times as many healthcare-related bachelors degrees as men. A NYT article from February 2015 lauded women for taking advantage of the stable, middle class jobs in healthcare, observing that As the job market has shifted, women, in general, have […]

By / 12.3.2014

Senator Schumer has made a plausible argument for why Obamacare was a political mistake.  I disagree. Democratic politicians have mainly defended Obamacare on the grounds of access, fairness and cost containment. But in the process, Democrats have missed an opportunity to show how Obamacare is a platform for entrepreneurial growth. Framed correctly, Obamacare could turn out […]